Skip to main content
. Author manuscript; available in PMC: 2008 Jun 8.
Published in final edited form as: Biochem Biophys Res Commun. 2007 Apr 10;357(3):737–742. doi: 10.1016/j.bbrc.2007.04.013

FIGURE 2. Demonstration of stable integration of shGrb2 into the COS7 genome.

FIGURE 2

A, PCR amplification of pU6+27-shGrb2 and pU6+27-shControl markers (NeoR and shRNA insert) in COS7shGrb2 and COS7shControl cells, respectively. After eight cellular passages in the continuous presence of 0.5 mg/ml neomycin, genomic DNA from COS7shGrb2 and COS7shControl cells were obtained and amplified by PCR in order to detect the neomycin resistance gene (NeoR: 513 bp) or each of the inserts encoded in the shRNA inserts (shGrb2: 706 bp or shControl: 657 bp). The PCR fragments of 706 bp (the shGrb2 insert) and 657 bp (the shControl insert) obtained from COS7shGrb2 and COS7shControl cells, respectively, were sequenced in both directions using the same PCR primers used for PCR amplification (not shown). B, As controls, the NeoR gene encoded exclusively in the pU6+27 plasmids was also PCR-amplified from COS7shGrb2, COS7shControl and COS7WT genomic DNA, as well as directly from the purified plasmids pU6+27-shGrb2 or pU6+27-shControl.